In a model of GBM heterogeneity, EGFRvIII-expressing cells produce secreted factors, such as IL-6 and LIF, which leads to cytokine co-receptor gp130-wild-type EGFR cross-talk and subsequent transactivation of wild-type EGFR to promote tumorigenesis.30 This evidence concerns the gene EGFR and glioblastoma.